Blueprint Medicines
BPMC
#2460
Rank
A$9.19 B
Marketcap
$144.77
Share price
-2.56%
Change (1 day)
41.35%
Change (1 year)

Blueprint Medicines (BPMC) - Cash on Hand

Cash on Hand as of September 2024 : A$1.12 Billion

According to Blueprint Medicines 's latest financial reports the company has A$1.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Blueprint Medicines - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$1.04 B-24.89%
2022-12-31A$1.38 B111.01%
2021-12-31A$0.65 B-41.96%
2020-12-31A$1.13 B64.17%
2019-12-31A$0.69 B-1.51%
2018-12-31A$0.70 B-18.7%
2017-12-31A$0.86 B190.3%
2016-12-31A$0.29 B33.02%
2015-12-31A$0.22 B286.93%
2014-12-31A$57.72 M2491.21%
2013-12-31A$2.22 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$67.28 M-94.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$62.38 M-94.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.78 B-30.56%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA